Skip to content

Analysis of Intravaginal Microbiota in Patients with Cervical Cancer and severe dysplasia

Analysis of Intravaginal Microbiota on Progression and Prognosis in Patients with Cervical Cancer and severe dysplasia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1040250087
Enrollment
110
Registered
2025-09-03
Start date
2023-08-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients diagnosed with cervical cancer or cervical severe dysplasia

Interventions

None listed

Sponsors

Kondo Eiji
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) Patients diagnosed with cervical cancer or cervical severe dysplasia between 2023 and 2027 2) Age 20 years or older at registration 3) Patientsls who provided written informed consent to participate in the study

Exclusion criteria

Exclusion criteria: Patients deemed ineligible for inclusion in the study by the principal investigator/co-investigator

Design outcomes

Primary

MeasureTime frame
Comparison of Intrauterine and Vaginal Microbiota

Secondary

MeasureTime frame
comparison of inflammatory cytokine expression and corisin

Contacts

Public ContactMichiko Kaneda

Mie university hospital

mkubo@med.mie-u.ac.jp+81-592321111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026